Revolutionary new implant for dry age-related macular degeneration
カートのアイテムが多すぎます
カートに追加できませんでした。
ウィッシュリストに追加できませんでした。
ほしい物リストの削除に失敗しました。
ポッドキャストのフォローに失敗しました
ポッドキャストのフォロー解除に失敗しました
Revolutionary new implant for dry age-related macular degeneration
-
ナレーター：
-
著者：
Send us your feedback
With over 84% of trial participants regaining the ability to read letters, numbers, and words. Mahi Muqit, senior vitreoretinal consultant at Moorfields Eye Hospital and the Institute of Ophthalmology at UCL, joins us to discuss the groundbreaking results from the PRIMA system clinical trial. Learn how the technology works and what this means for the future of treating patients with dry AMD and geographic atrophy.
If you would like to join the Macular Society's Research Participant Database, visit our website and sign up.
To watch our previous webinars, please visit our website.
The Macular Society has been supporting people with macular conditions for over 30 years. The right information and support can help people overcome their worries and retain their independence. We provide free information and support to those with macular disease, along with their family and friends. If you or a family member need advice or support, please make sure to reach out. No one has to face macular disease alone. Please call us on 0300 3030 111.